Tirzepatide was associated with significant declines in HbA1c and BMI for children and adolescents with type 2 diabetes, according to data from the SURPASS-PEDS trial. Tamara S. Hannon, MD, professor ...

GLP-1 therapies not only aid weight loss but also reduce intrusive food thoughts and shift taste perception, which may ...

Preclinical experiments and an ongoing phase 1 trial suggest that RES-010 may complement and enhance the efficacy of ...

Compared with usual care, GLP-1 receptor agonists tirzepatide and semaglutide may be cost-effective options for patients with ...

Learn how Orforglipron oral GLP-1 pill treats obesity and type 2 diabetes, supporting weight loss and glucose control. Discover benefits today!

Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% ...

Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% ...

Paris, France, Thursday, 18 September 2025) Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower ...